The latest and greatest new biomarkers - Which ones should we measure for risk prediction in our practice?

被引：9

作者：

de Lemos, James A. ^{[1
]}

机构：

[1] Univ Texas SW Med Ctr, Dallas, TX 75390 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2006年 / 166卷 / 22期

关键词：

D O I：

10.1001/archinte.166.22.2428

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2428 / 2430

页数：3

共 17 条

[1] Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old [J].

Adams, Kenneth F. ;

Schatzkin, Arthur ;

Harris, Tamara B. ;

Kipnis, Victor ;

Mouw, Traci ;

Ballard-Barbash, Rachel ;

Hollenbeck, Albert ;

Leitzmann, Michael F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (08) :763-778

[2] Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study [J].

Blankenberg, Stefan ;

McQueen, Matthew J. ;

Smieja, Marek ;

Pogue, Janice ;

Balion, Cynthia ;

Lonn, Eva ;

Rupprecht, Hans J. ;

Bickel, Christoph ;

Tiret, Laurence ;

Cambien, Francois ;

Gerstein, Hertzel ;

Muenzel, Thomas ;

Yusuf, Salim .

CIRCULATION, 2006, 114 (03) :201-208

[3] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[4] The effect of including C-reactive protein in cardiovascular risk prediction models for women [J].

Cook, Nancy R. ;

Buring, Julie E. ;

Ridker, Paul M. .

ANNALS OF INTERNAL MEDICINE, 2006, 145 (01) :21-29

[5] B-type natriuretic peptide in cardiovascular disease [J].

de Lemos, JA ;

McGuire, DK ;

Drazner, MH .

LANCET, 2003, 362 (9380) :316-322

[6] The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J].

de Lemos, JA ;

Morrow, DA ;

Bentley, JH ;

Omland, T ;

Sabatine, MS ;

McCabe, CH ;

Hall, C ;

Cannon, CP ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1014-1021

[7] N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease -: A Global Utilization of Strategies to Open occluded arteries (GUSTO)-IV substudy [J].

James, SK ;

Lindahl, B ;

Siegbahn, A ;

Stridsberg, M ;

Venge, P ;

Armstrong, P ;

Barnathan, ES ;

Califf, R ;

Topol, EJ ;

Simoons, ML ;

Wallentin, L .

CIRCULATION, 2003, 108 (03) :275-281

[8] N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults [J].

Kistorp, C ;

Raymond, I ;

Pedersen, F ;

Gustafsson, F ;

Faber, J ;

Hildebrandt, P .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (13) :1609-1616

[9] N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease [J].

Kragelund, C ;

Gronning, B ;

Kober, L ;

Hildebrandt, P ;

Steffensen, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (07) :666-675

[10] Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease [J].

Lloyd-Jones, Donald M. ;

Liu, Kiang ;

Tian, Lu ;

Greenland, Philip .

ANNALS OF INTERNAL MEDICINE, 2006, 145 (01) :35-42

← 1 2 →